A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer

NCT02632305 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Biliary Tract Cancer

Interventions

DRUG: nab-paclitaxel in combination with gemcitabine + cisplatin

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]